Literature DB >> 24821711

VDR status arbitrates the prometastatic effects of tumor-associated macrophages.

Yan Zhang1, Quanjun Guo1, Zhujun Zhang2, Nan Bai1, Ze Liu1, Min Xiong2, Yuquan Wei3, Rong Xiang4, Xiaoyue Tan5.   

Abstract

UNLABELLED: The relationship between tumor-associated macrophages (TAM) and epithelial-to-mesenchymal transition (EMT) during the initiation and progression of metastasis is still unclear. Here, a role for the vitamin D receptor (VDR) in metastasis was identified, as well as a role in the relationship between TAMs and EMT. First, the expression level of VDR was examined in clinical tissue from human patients with breast cancer or a mouse model of breast cancer with differential metastasis. These results revealed that VDR expression negatively correlates with metastasis in breast cancer. Second, coculture of VDR-overexpressing breast cancer cells with a macrophage cell line demonstrated that overexpression of VDR alleviated the prometastatic effect of cocultured macrophages on breast cancer cells. Furthermore, VDR overexpression abrogated the induction of EMT in breast cancer cells by cocultured macrophage cells, as measured by a loss of E-cadherin (CDH1) and induction of α-smooth muscle actin (α-SMA). TNFα in macrophage conditioned media inhibited VDR expression, whereas downregulation of VDR further mediated the promotion of TGFβ-induced EMT by TNFα. In addition, β-catenin expression was inhibited in VDR-overexpressing breast cancer cells and tumor xenografts. Finally, administration of calcitriol [1,25-(OH)2D3], an active vitamin D metabolite, exerted similar antimetastatic effects in breast cancer cells in vitro and a mouse model of breast cancer in vivo with preservation of VDR and suppression of β-catenin. IMPLICATIONS: VDR suppression by TNFα mediates the prometastatic effect of TAMs through enhancement of the β-catenin pathway. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24821711     DOI: 10.1158/1541-7786.MCR-14-0036

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  19 in total

Review 1.  Vitamin D and breast cancer: Past and present.

Authors:  JoEllen Welsh
Journal:  J Steroid Biochem Mol Biol       Date:  2017-07-23       Impact factor: 4.292

Review 2.  Function of the vitamin D endocrine system in mammary gland and breast cancer.

Authors:  JoEllen Welsh
Journal:  Mol Cell Endocrinol       Date:  2017-06-01       Impact factor: 4.102

Review 3.  New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers.

Authors:  Armel Hervé Nwabo Kamdje; Paul Faustin Seke Etet; Lorella Vecchio; Richard Simo Tagne; Jeremie Mbo Amvene; Jean-Marc Muller; Mauro Krampera; Kiven Erique Lukong
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

4.  Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.

Authors:  Abby L Johnson; Glendon M Zinser; Susan E Waltz
Journal:  Oncotarget       Date:  2015-06-30

5.  PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway.

Authors:  Yang Cheng; Yun Zhu; Jiajia Xu; Min Yang; Peiyu Chen; Wanfu Xu; Junhong Zhao; Lanlan Geng; Sitang Gong
Journal:  Mol Cancer       Date:  2018-01-24       Impact factor: 27.401

6.  JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.

Authors:  Jing Xun; Dekun Wang; Long Shen; Junbo Gong; Ruifang Gao; Lingfang Du; Antao Chang; Xiangrong Song; Rong Xiang; Xiaoyue Tan
Journal:  Oncotarget       Date:  2017-03-28

Review 7.  Regulation of Immune Cell Functions by Metabolic Reprogramming.

Authors:  Jaehong Kim
Journal:  J Immunol Res       Date:  2018-02-13       Impact factor: 4.818

Review 8.  Vitamin D as a Potential Preventive Agent For Young Women's Breast Cancer.

Authors:  Sarah M Bernhardt; Virginia F Borges; Pepper Schedin
Journal:  Cancer Prev Res (Phila)       Date:  2021-07-09

9.  miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells.

Authors:  Su'e Chang; Ling Gao; Yang Yang; Dongdong Tong; Bo Guo; Liying Liu; Zongfang Li; Tusheng Song; Chen Huang
Journal:  Oncotarget       Date:  2015-04-10

Review 10.  Vitamin D and the Epithelial to Mesenchymal Transition.

Authors:  María Jesús Larriba; Antonio García de Herreros; Alberto Muñoz
Journal:  Stem Cells Int       Date:  2016-01-06       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.